Quest Laboratories IPO Details: Price, Dates & Financials
The Quest Laboratories IPO GMP strength score is 7.3 out of 10, which the dashboard rates as Good. The Quest Laboratories IPO valuation is tagged Good. The Quest Laboratories IPO QIB category is reserved for 46.47% of the offer. The Quest Laboratories IPO NII/HNI category is reserved for 14.72% of the offer. The Quest Laboratories IPO Retail (RII) category is reserved for 33.68% of the offer. Live subscription numbers for the Quest Laboratories IPO are not yet available, and amounts are calculated at the upper price band of ₹97.
| Category | Sub (x) | Offered | Bid For |
|---|---|---|---|
| QIB | — | 2,067,600 (46%) | — |
| NII / HNI | — | 655,200 (15%) | — |
| Retail (RII) | — | 1,498,800 (34%) | — |
| Market Maker | — | 228,000 (5%) | — |
| Total | — | 4,449,600 (100%) | — |
* Amount calculated at upper price band (₹97) · ** Total includes all investor categories
- 1 Initiation of Refund 22 May 2024
- 2 Credit of Shares to Demat 22 May 2024
- Retail allocation is good at 34% of the total offering.
- HNI/NII demand is good at 15%.
- Institutional (QIB) interest is strong at 46%.
- The IPO P/E of 15x reflects a good valuation relative to typical market ranges.
- Pre-issue EPS of ₹4 compares to post-issue EPS of ₹6 after dilution.
This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.
GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.